Company overview
Sekisui Diagnostics develops, manufactures, and supplies clinical chemistry reagents, point-of-care tests, and pre-analytic systems for laboratories, hospitals, and healthcare providers worldwide. Their portfolio includes over 65 reagents for cardiovascular, diabetes, renal, and infectious disease testing, alongside rapid antigen and molecular tests like OSOM and Metrix for COVID-19, influenza, and respiratory health. They also provide specialty enzymes and materials for biotherapeutic manufacture, pharmaceutical production, and diagnostic reagents to support R&D and scale-up processes.
Sekisui Diagnostics is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, Diagnostics & Testing partner serving United States & Americas. Core focus areas include clinical chemistry reagents, point-of-care tests, diagnostic enzymes, pre-analytic systems, covid influenza tests.
Industry categories: Life Science Reagents, Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Sekisui Diagnostics include Reagent, Diagnostic — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://sekisuidiagnostics.com
- Categories
- Life Science Reagents, Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- clinical chemistry reagents, point-of-care tests, diagnostic enzymes, pre-analytic systems, covid influenza tests
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What diagnostic products does Sekisui Diagnostics offer for pharma and labs?
- Sekisui Diagnostics offers clinical chemistry reagents (>65 assays for cardiovascular, diabetes, renal, liver), point-of-care tests (OSOM rapid antigen, Metrix molecular for COVID/Flu), pre-analytic blood collection systems, and specialty enzymes for diagnostic and pharmaceutical manufacturing.
- What are the regulatory approvals for Sekisui's point-of-care tests?
- Products include CLIA-waived rapid tests with results in 10-30 minutes, high sensitivity/specificity; Metrix COVID/Flu is for point-of-care and home use; OSOM and Acucy brands serve professional and OTC markets.
- What geographies does Sekisui Diagnostics serve?
- Sekisui Diagnostics operates globally, supplying diagnostics to physicians, hospitals, labs, and alternate sites worldwide, with over 1.8 billion tests performed annually using their products.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
